Raymond James & Associates’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-14,200
Closed -$1K 3309
2016
Q4
$1K Sell
14,200
-2,400
-14% -$128K ﹤0.01% 3227
2016
Q3
$4K Buy
+16,600
New +$944K ﹤0.01% 3190

Other funds holding CTSH

Raymond James & Associates's CTSH Position: Q3 2024 in Review

Raymond James & Associates reduced its Cognizant (CTSH) stake by 7.8% in Q3 2024, selling an estimated $2.68M and leaving 423,413 shares worth $32.7M. The position accounts for 0.02% of the portfolio, ranked #591.

Raymond James & Associates first reported a position in CTSH in Q2 2013 and has held it in 46 quarters since. The position peaked at $50.4M in Q4 2021. 954 funds tracked by Wall St. Rank hold CTSH as of Q3 2024.

  • Raymond James & Associates held 423,413 shares of Cognizant worth $32.7M as of Q3 2024.
  • Raymond James & Associates sold 35,998 Cognizant shares in Q3 2024, an estimated $2.68M.
  • Cognizant made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #591 holding.
  • Raymond James & Associates first reported a position in Cognizant in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Cognizant position peaked at $50.4M in Q4 2021.
  • 954 funds tracked by Wall St. Rank held Cognizant as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.